According to the latest data from the Hong Kong Stock Exchange, on July 7th, JPMorgan Chase & Co. increased its holding in Asymchem Laboratories(Tianjin)Co.,Ltd. (HKEX: 06821) by 143,800 shares.
The transaction was executed at a price of approximately HK$111.632 per share, involving a total consideration of around HK$16.05 million.
Following this acquisition, JPMorgan's latest shareholding stands at approximately 2.5533 million shares, representing a stake of about 9.17% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments